NCT00003741View on ClinicalTrials.gov

Monoclonal Antibody Therapy in Treating Patients With Refractory Anaplastic Large Cell Lymphoma or Hodgkin's Lymphoma

PHASE1CompletedINTERVENTIONAL

Timeline

Start Date

February 28, 1999

Study Completion Date

December 31, 2007

Conditions

Lymphoma

Interventions

BIOLOGICAL

monoclonal antibody HeFi-1

Trial Locations (1)

02215

Beth Israel Deaconess Medical Center, Boston

All Listed Sponsors

lead

Beth Israel Deaconess Medical Center

OTHER

NCT00003741 - Monoclonal Antibody Therapy in Treating Patients With Refractory Anaplastic Large Cell Lymphoma or Hodgkin's Lymphoma | Biotech Hunter | Biotech Hunter